Shanley Shelburne
Medical · Pennington Gap, VANPI 1679927123
Payments from drug & device makers
Across 199 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$556
- AbbVie$526
- Lilly USA, LLC$400
- Amgen$369
- Abbott$325
- Biohaven Pharmaceutical Holding Company Ltd.$216
- plus $822 from 13 others
What the payments were for
- Food & beverage$3,203100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 47 | $556 |
| AbbVie | 31 | $526 |
| Lilly USA, LLC | 24 | $400 |
| Amgen(2 entities) | 29 | $369 |
| Abbott | 15 | $325 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $216 |
| AstraZeneca | 11 | $169 |
| Supernus Pharmaceuticals, Inc. | 1 | $143 |
| GSK | 8 | $116 |
| Biohaven Pharmaceuticals, Inc. | 3 | $66 |
| Pfizer | 3 | $61 |
| Amarin Pharma, Inc. | 4 | $61 |
| Boehringer Ingelheim | 3 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Novartis | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$143
How this compares
$3,213 in reported general payments places this provider in the 80th percentile of 632 medical providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 76 | $123,266 |
| MounjaroTirzepatide | 63 | $75,307 |
| EliquisApixaban | 68 | $64,535 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $41,827 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $30,268 |
| FarxigaDapagliflozin Propanediol | 25 | $21,639 |
| TrulicityDulaglutide | 22 | $21,580 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $14,567 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 19 | $10,107 |
| MyrbetriqMirabegron | 14 | $9,801 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,494 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 92 | $5,008 |
| Omeprazole | 191 | $3,978 |
| Duloxetine Hcl | 77 | $3,200 |
| Gabapentin | 173 | $2,901 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $556 | $123,26676 claims |
| Lilly USA, LLCMounjaro, Trulicity | $400 | $96,88785 claims |
| PfizerEliquis | $61 | $64,53568 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $169 | $51,90764 claims |
| GSKTrelegy Ellipta | $116 | $41,82735 claims |
| Boehringer IngelheimCombivent Respimat, Stiolto Respimat | $47 | $15,60130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 632 medical providers in Virginia.
Other medical in Pennington Gap
- Bryan UrquhartFredericksburg$264K
- Sara VillalonaRichmond$240K
- Sarah SafaLansdowne$171K
- Waseem GarbiaFairfax$114K
- Rana HassanAshburn$54K
- Brian LamFalls Church$51K
- Christine KesslerKing George$20K
- Janlyn AnthonyRichmond$18K
- Cara DepanfilisNorfolk$17K
- Nicholas DeptulaRichmond$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.